Filing Flows › Ocugen (OCGN) › Q2 2026
Ocugen (OCGN) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 6, 2026
Ocugen (OCGN) reported revenue of $1.5M for the second quarter 2026 (Q2 2026), +8% from a year earlier and -3% from the quarter before.
Ocugen, Q2 2026: revenue $1.5M (+8% year over year), net loss $24.9M, operating cash flow −$12.2M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.5M | -3% | +8% |
| Operating profit | −$16.4M | — | — |
| Net earnings | −$24.9M | — | — |
| Operating cash flow | −$12.2M | — | — |
What changed
Revenue was $1.5M in Q2 2026, up 8% year over year and down 3% from the previous quarter.
Operating costs exceeded revenue by $16.4M, an operating margin of -1105.1%. Total costs grew 18% against revenue growth of 8%. The fastest-growing cost line was Research & development (+27%). The quarter ended with a net loss of $24.9M, wider than the previous quarter's $19.2M loss.
Operating cash flow was −$12.2M. Non-cash charges added back $600K of depreciation and $1.8M of share-based compensation. Working capital and other items added $10.2M. Capital expenditures of $21K exceeded it, leaving free cash flow of −$12.2M.
Questions
What was Ocugen's revenue in the second quarter 2026?
Ocugen (OCGN) reported revenue of $1.5M for the second quarter 2026 (Q2 2026), +8% from a year earlier and -3% from the quarter before.
Source: Ocugen 10-Q on SEC EDGAR.